## Abstract 5′‐__O__‐[__N__‐(Salicyl)sulfamoyl]adenosine (Sal‐AMS, 1) is a potent inhibitor of the bifunctional enzyme salicyl‐AMP ligase in __Mycobacterium tuberculosis__. This inhibitor acts by disrupting the biosynthesis of the mycobactin siderophores that are essential for the process of iron a
Synthesis of deuterium-labeled zaleplon-d5 as an internal standard
✍ Scribed by Ajam C. Shaikh; Chinpiao Chen
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- French
- Weight
- 179 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Zaleplon is licensed for the short‐term treatment of insomnia. Excessive usage causes side effects; hence, the drug is controlled. Identifying zaleplon in a drug abuser requires an isotope‐labeled internal standard. This work presents a synthesis of stable isotope‐labeled internal standard for zaleplon, zaleplon‐d~5~, by a five‐step synthetic sequence. Copyright © 2008 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract The synthesis of various D‐labeled perfume ingredients (orris‐like, sandalwood‐like, musky, and amber‐like) is presented. These substances, possessing practically identical H~2~O/solid and solid/gas partition coefficients as their unlabeled analogues, are used as internal standards for
## Abstract The Batcho–Leimgruber strategy was employed to synthesize 3‐(2‐dimethylamino‐[^2^H~4~]‐ethyl)‐1__H__‐indol‐5‐ol (bufotenine, 5‐HO‐DMT) (**8**) from commercial 3‐methyl‐4‐nitro‐phenol (**1**), benzyl bromide and __N,N__–dimethylformamide–dimethylacetal. Compound **4** was synthesized fro
The Batcho-Leimgruber strategy was employed to synthesize 5-[ 2 H 3 ]-methoxy-1 H-indole 4 from commercially available 5-hydroxy-2-nitrotoluene 1 and CD 3 I. Compound 4 was treated with oxalyl chloride, dimethylamine and lithium aluminum hydride to yield 5-[ 2 H 3 ]-methoxy-N,N-dimethyltryptamine 6.
## Abstract Four deuterium‐labelled benzodiazepines were prepared for use as internal standards in the quantification of chlordiazepoxide, demethyldiazepam, diazepam, and oxazepam at low levels in body fluids by selected ion monitoring. The method described provides a way to introduce cleanly and i